Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_assertion type Assertion NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_head.
- NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_assertion description "[The level of CSF neuroserpin was significantly higher in AD compared with controls and DLB, whereas CSF alpha(1)-antichymotrypsin and alpha(1)-antitrypsin were significantly higher in both AD and DLB groups than in controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_provenance.
- NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_assertion evidence source_evidence_literature NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_provenance.
- NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_assertion SIO_000772 17761554 NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_provenance.
- NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_assertion wasDerivedFrom befree-20150227 NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_provenance.
- NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_assertion wasGeneratedBy ECO_0000203 NP619662.RAzexiQrCLIjmzGAQ3i-hQ7wTOS2m6MkixUXkm3_N-4dQ130_provenance.